SCHEMBL26675452

SCHEMBL26675452

COc1ccccc1C(=O)n1nc(N)c2ccc(C3CC3C(F)(F)F)nc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MAPT P10636 7/20 0.42
▸ HTT P42858 6/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ TP53 P04637 2/20 0.42
▸ PKM P14618 1/20 0.42
▸ POLB P06746 4/20 0.41
▸ F2 P00734 6/20 0.41
▸ F12 P00748 2/20 0.40
▸ TTR P02766 1/20 0.40
▸ GAA P10253 2/20 0.38
▸ MGAM O43451 1/20 0.38
▸ AMY1A P0DUB6 1/20 0.38
▸ MIF P14174 1/20 0.38
▸ SI P14410 1/20 0.38
▸ MGAM2 Q2M2H8 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29767948 1.00 ALOX15 (0.44) ALOX15HSD17B10MAPTHTTSMN1; SMN2
SCHEMBL29767956 0.89 ALOX15 (0.46) ALOX15HSD17B10MAPTHTTSMN1; SMN2
SCHEMBL26675362 0.89 ALOX15 (0.46) ALOX15HSD17B10MAPTHTTSMN1; SMN2
SCHEMBL30675610 0.89 ALOX15 (0.46) ALOX15HSD17B10MAPTHTTSMN1; SMN2
SCHEMBL26675344 0.88 ALOX15 (0.47) ALOX15HSD17B10MAPTHTTSMN1; SMN2
SCHEMBL26834610 0.88 ALOX15 (0.47) ALOX15HSD17B10MAPTHTTSMN1; SMN2
SCHEMBL29767952 0.88 ALOX15 (0.47) ALOX15HSD17B10MAPTHTTSMN1; SMN2
SCHEMBL26834617 0.87 ENPP3 (0.38) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL26675432 0.84 ALOX15 (0.48) ALOX15HSD17B10MAPTHTTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL26675303 0.84 ALOX15 (0.45) ALOX15HSD17B10MAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES P2RY1, P2RX1, P2RX5 ALOX15 3863/4885HSD17B10 2897/4885MAPT 3058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback